BACKGROUND: Age trends in estradiol and estrone levels in men and how lifestyle factors, comorbid conditions, testosterone, and sex hormone-binding globulin affect these age trends remain poorly understood, and were examined in men of the Framingham Heart Study. METHODS: Estrone and estradiol concentrations were measured in morning fasting samples using liquid chromatography tandem mass spectrometry in men of Framingham Offspring Generation. Free estradiol was calculated using a law of mass action equation. RESULTS: There were 1,461 eligible men (mean age [±SD] 61.1±9.5 years and body mass index [BMI] 28.8±4.5kg/m(2)). Total estradiol and estrone were positively associated with age, but free estradiol was negatively associated with age. Age-related increase in total estrone was greater than that in total estradiol. Estrone was positively associated with smoking, BMI, and testosterone, and total and free estradiol with diabetes, BMI, testosterone, and comorbid conditions; additionally, free estradiol was associated negatively with smoking. Collectively, age, BMI, testosterone, and other health and behavioral factors explained only 18% of variance in estradiol, and 9% of variance in estrone levels. Men in the highest quintile of estrone levels had significantly higher age and BMI, and a higher prevalence of smoking, diabetes, and cardiovascular disease than others, whereas those in the highest quintile of estradiol had higher BMI than others. CONCLUSIONS: Total estrone and estradiol levels in men, measured using liquid chromatography tandem mass spectrometry, revealed significant age-related increases that were only partially accounted for by cross-sectional differences in BMI, diabetes status, and other comorbidities and health behaviors. Longitudinal studies are needed to confirm these findings.
BACKGROUND: Age trends in estradiol and estrone levels in men and how lifestyle factors, comorbid conditions, testosterone, and sex hormone-binding globulin affect these age trends remain poorly understood, and were examined in men of the Framingham Heart Study. METHODS: Estrone and estradiol concentrations were measured in morning fasting samples using liquid chromatography tandem mass spectrometry in men of Framingham Offspring Generation. Free estradiol was calculated using a law of mass action equation. RESULTS: There were 1,461 eligible men (mean age [±SD] 61.1±9.5 years and body mass index [BMI] 28.8±4.5kg/m(2)). Total estradiol and estrone were positively associated with age, but free estradiol was negatively associated with age. Age-related increase in total estrone was greater than that in total estradiol. Estrone was positively associated with smoking, BMI, and testosterone, and total and free estradiol with diabetes, BMI, testosterone, and comorbid conditions; additionally, free estradiol was associated negatively with smoking. Collectively, age, BMI, testosterone, and other health and behavioral factors explained only 18% of variance in estradiol, and 9% of variance in estrone levels. Men in the highest quintile of estrone levels had significantly higher age and BMI, and a higher prevalence of smoking, diabetes, and cardiovascular disease than others, whereas those in the highest quintile of estradiol had higher BMI than others. CONCLUSIONS: Total estrone and estradiol levels in men, measured using liquid chromatography tandem mass spectrometry, revealed significant age-related increases that were only partially accounted for by cross-sectional differences in BMI, diabetes status, and other comorbidities and health behaviors. Longitudinal studies are needed to confirm these findings.
Entities:
Keywords:
Age trends; Age-related changes in estrone and estradiol; Determinants of estrogen levels in men.; Estrogen levels in men; LC-MS/MS
Authors: Marcello Maggio; Gian Paolo Ceda; Fulvio Lauretani; Stefania Bandinelli; E Jeffrey Metter; Andrea Artoni; Elisa Gatti; Carmelinda Ruggiero; Jack M Guralnik; Giorgio Valenti; Shari M Ling; Shehzad Basaria; Luigi Ferrucci Journal: J Clin Endocrinol Metab Date: 2008-12-02 Impact factor: 5.958
Authors: M Cushman; C Legault; E Barrett-Connor; M L Stefanick; C Kessler; H L Judd; P A Sakkinen; R P Tracy Journal: Circulation Date: 1999-08-17 Impact factor: 29.690
Authors: Willem de Ronde; Yvonne T van der Schouw; Majon Muller; Diederick E Grobbee; Louis J G Gooren; Huibert A P Pols; Frank H de Jong Journal: J Clin Endocrinol Metab Date: 2004-10-27 Impact factor: 5.958
Authors: A Hautanen; M Mänttäri; M Kupari; S Sarna; V Manninen; M H Frick; H Adlercreutz Journal: J Steroid Biochem Mol Biol Date: 1993-08 Impact factor: 4.292
Authors: Eric S Orwoll; Carrie M Nielson; Fernand Labrie; Elizabeth Barrett-Connor; Jane A Cauley; Steven R Cummings; Kristine Ensrud; Magnus Karlsson; Edith Lau; P C Leung; Osten Lunggren; Dan Mellström; Alan L Patrick; Marcia L Stefanick; Kozo Nakamura; Noriko Yoshimura; Joseph Zmuda; Liesbeth Vandenput; Claes Ohlsson Journal: J Clin Endocrinol Metab Date: 2010-07-28 Impact factor: 5.958
Authors: Frank Z Stanczyk; Michael M Cho; David B Endres; John L Morrison; Stan Patel; Richard J Paulson Journal: Steroids Date: 2003-12 Impact factor: 2.668
Authors: Victoria L Nutsch; Margaret R Bell; Ryan G Will; Weiling Yin; Andrew Wolfe; Ross Gillette; Juan M Dominguez; Andrea C Gore Journal: Mol Cell Endocrinol Date: 2016-12-20 Impact factor: 4.102
Authors: Louise A Brinton; Tim J Key; Laurence N Kolonel; Karin B Michels; Howard D Sesso; Giske Ursin; Stephen K Van Den Eeden; Shannon N Wood; Roni T Falk; Dominick Parisi; Chantal Guillemette; Patrick Caron; Véronique Turcotte; Laurel A Habel; Claudine J Isaacs; Elio Riboli; Elisabete Weiderpass; Michael B Cook Journal: J Clin Oncol Date: 2015-05-11 Impact factor: 44.544
Authors: Robert M Grant; Marion Pellegrini; Patricia A Defechereux; Peter L Anderson; Michelle Yu; David V Glidden; Joshua O'Neal; Jenna Yager; Shalender Bhasin; Jae Sevelius; Madeline B Deutsch Journal: Clin Infect Dis Date: 2021-10-05 Impact factor: 20.999
Authors: Camila Manrique-Acevedo; Francisco I Ramirez-Perez; Jaume Padilla; Victoria J Vieira-Potter; Annayya R Aroor; Brady J Barron; Dongqing Chen; Dominic Haertling; Cory Declue; James R Sowers; Luis A Martinez-Lemus Journal: Endocrinology Date: 2017-06-01 Impact factor: 4.736
Authors: Thomas G Travison; Christopher J O'Donnell; Shalender Bhasin; Joseph M Massaro; Udo Hoffmann; Ramachandran S Vasan; Ralph B D'Agostino; Shehzad Basaria Journal: J Clin Endocrinol Metab Date: 2016-03-01 Impact factor: 5.958
Authors: A Richard; S Rohrmann; L Zhang; M Eichholzer; S Basaria; E Selvin; A S Dobs; N Kanarek; A Menke; W G Nelson; E A Platz Journal: Andrology Date: 2014-03-20 Impact factor: 3.842
Authors: Guneet Kaur Jasuja; Thomas G Travison; Joanne M Murabito; Maithili N Davda; Adam J Rose; Shehzad Basaria; Andrea Coviello; Ramachandran S Vasan; Ralph D'Agostino; Shalender Bhasin Journal: J Gerontol A Biol Sci Med Sci Date: 2017-08-01 Impact factor: 6.053